Navigation Links
Dr. Peter Diamandis Joins Tribogenics Advisory Board
Date:12/6/2012

MARINA DEL REY, Calif., Dec. 6, 2012 /PRNewswire/ -- Tribogenics, a producer of innovative X-ray sources, announced today that Dr. Peter Diamandis, Chairman and CEO of the X PRIZE Foundation (www.xprize.org), has joined its Advisory Board. Best known for the $10 million Ansari X PRIZE for private spaceflight, the X PRIZE Foundation is a non-profit organization focused on designing and launching global incentive prizes to drive radical breakthroughs for the benefit of humanity. Diamandis is also the New York Times Bestselling author of Abundance – The Future Is Better Than You Think.

(Photo: http://photos.prnewswire.com/prnh/20121206/LA24744)

"Peter Diamandis is the embodiment of innovative thinking and shares our passion for the growth of exponential technologies. We're thrilled to have him on our team and are confident that his insights will add tremendous value as we continue advancing the technology of our disruptive X-ray sources," said Dale Fox, President and CEO of Tribogenics.

"Tribogenics is building the future of X-ray sources and is on the path to create real change," said Dr. Diamandis. "I believe you must be willing to take risks in order to have true breakthroughs and I look forward to working with the company as they bring new capabilities and innovative devices to market."

Tribogenics recently announced a $6.2 million Series A financing round led by Founders Fund that allows the company to expedite time to market by hiring additional engineers and scientists and to expand the size of its internal R&D facility. The company previously received $2.5M in funding from Flywheel Ventures and other angel investors.

About Dr. Peter Diamandis

Dr. Peter H. Diamandis is an international pioneer in the fields of innovation, incentive competitions and commercial space.

In the field of Innovation, Diamandis is Chairman and CEO of the X PRIZE Foundation, best known for its $10 million Ansari X PRIZE for private spaceflight.  Today the X PRIZE leads the world in designing and operating large-scale global competitions to solve market failures.  He is also the Co-Founder and Executive Chairman of Singularity University, a graduate-level Silicon Valley institution that studies exponentially growing technologies, their ability to transform industries and solve humanity's grand challenges.

In the field of commercial space, Diamandis is Co-Founder/Co-Chairman of Planetary Resources, a company designing spacecraft to enable the detection and mining of asteroid for precious materials.  He is the also Co-Founder and Vice Chairman of Space Adventures, the only company to have brokered the launches of private citizens to the International Space Station, and co-Founder, past-CEO of Zero Gravity Corporation providing weightless parabolic flights.

Diamandis has won multiple awards, including the first Heinlein Laureate, the 2010 Economist "No Boundaries" Innovator of the Year Award, the 2007 Arthur C. Clarke Award, the 2006 Lindbergh Award, the 2006 Neil Armstrong Award and first place in the Estes rocket design contest when he was an 8th grader.

He earned an undergraduate degree in Molecular Genetics and a graduate degree in Aerospace Engineering from the Massachusetts Institute of Technology, and received his M.D. from Harvard Medical School.

About Tribogenics

Tribogenics develops small, scalable, low-voltage X-ray sources that power transformative solutions in resource exploration, industrial, military and medical imaging industries. Based on a DARPA-funded initiative at UCLA, Tribogenics technology eliminates the need for high voltage and enables the use of X-rays in a variety of applications that aren't possible with existing technology. To learn more visit www.tribogenics.com.


'/>"/>
SOURCE Tribogenics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Names Peter F. McAree Chief Financial Officer
2. Landauer, Inc. Appoints Peter Cempellin To President Of Landauer Radiation Measurement
3. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
4. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
5. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
6. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
7. David F. Harty Joins Systech International as Vice President
8. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
9. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
10. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
11. Anthony Creed Joins DDSTUDIO As GM, Experience Design
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... 12, 2017 , ... Health Literacy Innovations (HLI), creator of ... and the Cancer Patient Education Network (CPEN), an independent professional organization that shares ... strategic alliance. , As CPEN’s strategic partner, HLI will help support CPEN ...
Breaking Medicine News(10 mins):